MTX-211 Inhibits GSH Synthesis through Keap1/NRF2/GCLM Axis and Exerts Antitumor Effects in Bladder Cancer
Globally, bladder cancer (BLCA) is still the leading cause of death in patients with tumors. The function and underlying mechanism of MTX-211, an EFGR and PI3K kinase inhibitor, have not been elucidated. This study examined the function of MTX-211 in BLCA cells using in vitro and in vivo assays. RNA...
Main Authors: | Bing Hu, Ru Chen, Ming Jiang, Situ Xiong, An Xie, Xiaoqiang Liu, Bin Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/8/7608 |
Similar Items
-
Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer
by: Song Wang, et al.
Published: (2022-10-01) -
Modulation of NRF2/KEAP1 Signaling in Preeclampsia
by: Giovanni Tossetta, et al.
Published: (2023-06-01) -
The KEAP1-NRF2 pathway: Targets for therapy and role in cancer
by: Simone Adinolfi, et al.
Published: (2023-07-01) -
The KEAP1–NRF2 System in Cancer
by: Keiko Taguchi, et al.
Published: (2017-05-01) -
Genetic hyperactivation of Nrf2 causes larval lethality in Keap1a and Keap1b-double-knockout zebrafish
by: Lixuan Bian, et al.
Published: (2023-06-01)